Business
Dual-Targeting Drug Halts Tau Accumulation in Alzheimer’s - Neuroscience News
Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in Alzheimer's disease.
By: Neurosciencenews.com
- Oct 05 2024
- 0
- 0 Views
Summary: Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in Alzheimer’s disease. This peptide inhibitor, RI-AG03, effectively pre… [+8488 chars]